Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Chiesi Farmaceutici SPA

https://www.chiesi.com/en

Latest From Chiesi Farmaceutici SPA

Mystery Solved? GenSight’s Gene Therapy Does Move Between Eyes

Company boosted by animal study which helps answer riddle of improvement in untreated eye.

Ophthalmic Gene Therapy

Blow To AZ As FDA Rejects COPD Contender

Issued with a complete response letter from the FDA, the company says it will now submit newer data showing the combination's effects on exacerbations.

 

Respiratory FDA

GenSight Undeterred By Gene Therapy’s Placebo Puzzle

Phase III success at 96 weeks sets up GenSight blindness therapy for EU filing, but puzzle of placebo arm benefits remain

Gene Therapy Ophthalmic

AstraZeneca’s COPD Triple Combo Drug Succeeds in ETHOS Phase III, Setting Up GSK Showdown

The triple-combination treatment significantly reduced COPD exacerbations compared to older dual therapies in the Phase III ETHOS study, providing a boost to AstraZeneca as it closes in on approvals in the US and Europe.

Clinical Trials Companies
See All

Company Information

Advertisement
Advertisement
UsernamePublicRestriction

Register